We initially identified 1337 (FClog2 ≤ 0.5, p ≤ 0.05) potential HMGA2-targets by exploration of expression profiling data of the breast cancer cell line MDA-MB-231 with HMGA2 knock-down (GSE4374137). This evidence concerns the gene HMGA2 and breast cancer.